Intellectual Property Service Initiative Targets High-Value Patent Growth in Datong's Biomedical Sector

Deep News
08/10

China Quality News has reported that to bolster the national and provincial drive for a strong intellectual property (IP) framework, focusing on the core goal of cultivating high-value patents, the Development Zone Branch of the Datong Municipal Market Regulation Bureau in Shanxi Province recently organized a team of IP specialists. They visited biomedical companies within the zone to conduct a targeted assistance campaign for IP development.

The biomedical industry, characterized by its strong innovation profile, is a key battleground for fostering high-value invention patents. While research and development investment by local pharmaceutical firms is on the rise, a common issue of "prioritizing R&D over strategic layout" persists. This has led to a shortage of high-value patent reserves, an incomplete protection system for core technology patents, and suboptimal efficiency in converting innovations into practical results.

Leveraging its market regulatory functions, the branch is balancing supervision with proactive service. By focusing on the cultivation of high-value patents, it is actively reaching out to enterprises to provide precise solutions to their difficulties. At the technology center of Shanxi Shuangyan Pharmaceutical, staff held discussions with the company's R&D management team. They explained the application conditions, the "dual-station chief" operation mechanism, and the full-chain service functions related to the provincial IP service station policy, encouraging the company to leverage its R&D platform advantages and build a long-term patent cultivation mechanism through the service station.

The discussions centered on guiding high-value patent cultivation. In areas such as deep processing of traditional Chinese medicine, formulation process improvement, drug testing, and intelligent pharmaceutical manufacturing, the team advised the company to shift away from a mindset focused solely on the quantity of patents. Instead, they encouraged a focus on core technologies with market prospects and the potential to build competitive barriers. The guidance included systematic patent mining, forward-looking patent layout, and the construction of high-quality patent portfolios, aiming to cultivate a batch of high-value invention patents that support the company's long-term growth.

Additionally, the team introduced supporting services like patent navigation, priority examination, and fee reduction to lower the cost of IP protection for the enterprise. Simultaneously, enforcement officers conducted compliance education, interpreting relevant provisions of the Patent Law and warning against risks such as abnormal patent applications and false patent advertising. They guided the company in standardizing patent marking management and improving its internal IP management systems.

Staff also presented pro-business policies, including patent pledge financing and provincial patent award applications, advising the company on how to monetize the intangible assets of its high-value patents and open up channels for the transformation of scientific and technological achievements. Going forward, the Development Zone Branch will continue to implement the requirements for building IP service stations, firmly focus on the core task of cultivating high-value patents, and conduct regular IP guidance visits to parks and enterprises. The goal is to guide innovation entities in strengthening their layout of core technology patents, continuously expand the region's reserve of high-value patents, and empower the high-quality development of Datong Economic Development Zone's pharmaceutical industry with robust IP assets.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10